Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8712 USD | -2.00% | -0.06% | -18.58% |
Mar. 21 | Transcript : MiNK Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
Mar. 21 | MiNK Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 30.23M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -36M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.69
x | P/E ratio 2025 * |
-1.31
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.66% |
Latest transcript on MiNK Therapeutics, Inc.
1 day | -2.00% | ||
1 week | -0.06% | ||
Current month | -4.08% | ||
1 month | -5.06% | ||
3 months | +1.30% | ||
6 months | -2.30% | ||
Current year | -18.58% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.8712 | -2.00% | 40,066 |
24-04-24 | 0.889 | +2.07% | 38,552 |
24-04-23 | 0.871 | -2.57% | 97,040 |
24-04-22 | 0.894 | +2.02% | 40,075 |
24-04-19 | 0.8763 | +0.53% | 40,426 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.58% | 30.23M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.75% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- INKT Stock